Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis

Por Coelho, Teresa, Merlini, Giampaolo, Bulawa, Christine E., Fleming, James A., Judge, Daniel P., Kelly, Jeffery W., Maurer, Mathew S., Planté-Bordeneuve, Violaine, Labaudinière, Richard, Mundayat, Rajiv, Riley, Steve, Lombardo, Ilise, Huertas, Pedro
Publicado no Neurol Ther (2016)

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

Por Bulawa, Christine E., Connelly, Stephen, DeVit, Michael, Wang, Lan, Weigel, Charlotte, Fleming, James A., Packman, Jeff, Powers, Evan T., Wiseman, R. Luke, Foss, Theodore R., Wilson, Ian A., Kelly, Jeffery W., Labaudinière, Richard
Publicado em 2012

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

Por Coelho, Teresa, Maia, Luis F., da Silva, Ana Martins, Cruz, Márcia W., Planté-Bordeneuve, Violaine, Suhr, Ole B., Conceiçao, Isabel, Schmidt, Hartmut H.-J., Trigo, Pedro, Kelly, Jeffery W., Labaudinière, Richard, Chan, Jason, Packman, Jeff, Grogan, Donna R.
Publicado em 2013

Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial

Por Coelho, Teresa, Maia, Luis F., Martins da Silva, Ana, Waddington Cruz, Marcia, Planté-Bordeneuve, Violaine, Lozeron, Pierre, Suhr, Ole B., Campistol, Josep M., Conceição, Isabel Maria, Schmidt, Hartmut H.-J., Trigo, Pedro, Kelly, Jeffery W., Labaudinière, Richard, Chan, Jason, Packman, Jeff, Wilson, Amy, Grogan, Donna R.
Publicado em 2012